Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-13

Clinical Trial Update: Montelukast Use in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining montelukast for rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast (Montelukast)

Snippet

Sponsor: Noha Mansour | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED